207 related articles for article (PubMed ID: 11746780)
21. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia.
Krämer-Albers EM; Gehrig-Burger K; Thiele C; Trotter J; Nave KA
J Neurosci; 2006 Nov; 26(45):11743-52. PubMed ID: 17093095
[TBL] [Abstract][Full Text] [Related]
22. A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse.
Nadon NL; Arnheiter H; Hudson LD
J Neurochem; 1994 Sep; 63(3):822-33. PubMed ID: 7519661
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis in vivo of the double mutant mouse deficient in both proteolipid protein (PLP) and myelin basic protein (MBP) in the central nervous system.
Stoffel W; Boison D; Büssow H
Cell Tissue Res; 1997 Aug; 289(2):195-206. PubMed ID: 9211822
[TBL] [Abstract][Full Text] [Related]
24. Myelin proteolipid DM20: evidence for function independent of myelination.
Nadon NL; Miller S; Draeger K; Salvaggio M
Int J Dev Neurosci; 1997 Jun; 15(3):285-93. PubMed ID: 9253653
[TBL] [Abstract][Full Text] [Related]
25. Evolution of a neuroprotective function of central nervous system myelin.
Yin X; Baek RC; Kirschner DA; Peterson A; Fujii Y; Nave KA; Macklin WB; Trapp BD
J Cell Biol; 2006 Jan; 172(3):469-78. PubMed ID: 16449196
[TBL] [Abstract][Full Text] [Related]
26. Human myelin proteolipid protein structure and lipid bilayer stacking.
Ruskamo S; Raasakka A; Pedersen JS; Martel A; Škubník K; Darwish T; Porcar L; Kursula P
Cell Mol Life Sci; 2022 Jul; 79(8):419. PubMed ID: 35829923
[TBL] [Abstract][Full Text] [Related]
27. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
Zöller I; Büssow H; Gieselmann V; Eckhardt M
Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
[TBL] [Abstract][Full Text] [Related]
28. Myelin proteolipid protein: function in myelin structure is distinct from its role in oligodendrocyte development.
Nadon NL; West M
Dev Neurosci; 1998; 20(6):533-9. PubMed ID: 9858842
[TBL] [Abstract][Full Text] [Related]
29. Plp gene regulation in the developing murine optic nerve: correlation with oligodendroglial process alignment along the axons.
Thomson CE; Vouyiouklis DA; Barrie JA; Wease KN; Montague P
Dev Neurosci; 2005; 27(1):27-36. PubMed ID: 15886482
[TBL] [Abstract][Full Text] [Related]
30. Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes.
Meng F; Zolova O; Kokorina NA; Dobretsova A; Wight PA
J Neurosci Res; 2005 Nov; 82(3):346-56. PubMed ID: 16155935
[TBL] [Abstract][Full Text] [Related]
31. The early phenotype associated with the jimpy mutation of the proteolipid protein gene.
Thomson CE; Anderson TJ; McCulloch MC; Dickinson P; Vouyiouklis DA; Griffiths IR
J Neurocytol; 1999 Mar; 28(3):207-21. PubMed ID: 10617903
[TBL] [Abstract][Full Text] [Related]
32. Characterization of myelination in the developing zebrafish.
Brösamle C; Halpern ME
Glia; 2002 Jul; 39(1):47-57. PubMed ID: 12112375
[TBL] [Abstract][Full Text] [Related]
33. Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.
Fowler JH; Edgar JM; Pringle A; McLaughlin M; McCulloch J; Griffiths IR; Garbern JY; Nave KA; Dewar D
J Neurosci Res; 2006 Jul; 84(1):68-77. PubMed ID: 16625661
[TBL] [Abstract][Full Text] [Related]
34. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes.
Campagnoni AT; Skoff RP
Brain Pathol; 2001 Jan; 11(1):74-91. PubMed ID: 11145205
[TBL] [Abstract][Full Text] [Related]
35. Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus.
Verity AN; Bredesen D; Vonderscher C; Handley VW; Campagnoni AT
J Neurochem; 1993 Feb; 60(2):577-87. PubMed ID: 7678286
[TBL] [Abstract][Full Text] [Related]
36. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
[TBL] [Abstract][Full Text] [Related]
37. His36Pro point-mutated proteolipid protein retained in the endoplasmic reticulum of oligodendrocytes in the shaking pup.
Song J; Goetz BD; Duncan ID
Glia; 2006 Feb; 53(3):257-65. PubMed ID: 16265668
[TBL] [Abstract][Full Text] [Related]
38. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin.
Stecca B; Southwood CM; Gragerov A; Kelley KA; Friedrich VL; Gow A
J Neurosci; 2000 Jun; 20(11):4002-10. PubMed ID: 10818135
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice.
Jung M; Sommer I; Schachner M; Nave KA
J Neurosci; 1996 Dec; 16(24):7920-9. PubMed ID: 8987820
[TBL] [Abstract][Full Text] [Related]
40. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination.
Ye P; Li L; Lund PK; D'Ercole AJ
Brain Res Dev Brain Res; 2002 Jun; 136(2):111-21. PubMed ID: 12101028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
